CRBU

Caribou Biosciences Inc

Jul 16 • 04:00PM ET

1.83

Dollar change +0.22
Percentage change 13.66	%

Healthcare • Biotechnology • USA • NASD

Peers: EDIT CRSP BEAM NTLA VRTX QURE BLUE PSTX SGMO DTIL

| Held by: VTI VXF SCHA DFAT NXTE DFAC XDNA SCHB DFAS PRFZ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.62	Insider Own	12.94%	Shs Outstand	93.00M	Perf Week	4.57%
Market Cap	170.20M	Forward P/E	-	EPS next Y	-1.23	Insider Trans	0.22%	Shs Float	80.97M	Perf Month	64.86%
Enterprise Value	-12.05M	PEG	-	EPS next Q	-0.39	Inst Own	50.11%	Short Float	7.64%	Perf Quarter	128.69%
Income	-147.86M	P/S	17.16	EPS this Y	9.52%	Inst Trans	-14.46%	Short Ratio	4.48	Perf Half Y	18.06%
Sales	9.92M	P/B	0.78	EPS next Y	17.50%	ROA	-43.46%	Short Interest	6.19M	Perf YTD	15.09%
Book/sh	2.34	P/C	0.82	EPS next 5Y	4.16%	ROE	-52.76%	52W High	3.00 -38.99%	Perf Year	-9.41%
Cash/sh	2.24	P/FCF	-	EPS past 3/5Y	-14.13% -33.41%	ROIC	-61.22%	52W Low	0.66 177.27%	Perf 3Y	-72.65%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	1.36% 11.54%	Gross Margin	55.82%	Volatility	9.05% 9.47%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-1.21	EPS Y/Y TTM	-11.68%	Oper. Margin	-1648.79%	ATR (14)	0.13	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.63	Sales Y/Y TTM	-70.31%	Profit Margin	-1490.84%	RSI (14)	70.01	Recom	1.29
Dividend Gr. 3/5Y	- -	Current Ratio	7.63	EPS Q/Q	6.54%	SMA20	26.03%	Beta	2.48	Target Price	9.67
Payout	-	Debt/Eq	0.12	Sales Q/Q	-3.13%	SMA50	53.91%	Rel Volume	1.25	Prev Close	1.61
Employees	147	LT Debt/Eq	0.11	Earnings	May 08 AMC	SMA200	25.89%	Avg Volume	1.38M	Price	1.83
IPO	Jul 23, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.92% 34.46%	Trades		Volume	1,730,806	Change	13.66%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-03-24	Downgrade	Evercore ISI	Outperform → In-line	$13 → $3
Nov-08-23	Initiated	Cantor Fitzgerald	Neutral
Oct-31-23	Initiated	Evercore ISI	Outperform	$13
Jul-11-23	Initiated	Truist	Buy	$23
Feb-18-22	Initiated	RBC Capital Mkts	Outperform	$22
Dec-01-21	Initiated	Oppenheimer	Outperform	$36
Nov-30-21	Initiated	H.C. Wainwright	Buy	$28
Nov-15-21	Upgrade	Citigroup	Neutral → Buy	$27
Aug-17-21	Initiated	SVB Leerink	Outperform	$32
Aug-17-21	Initiated	Citigroup	Neutral	$27
Aug-17-21	Initiated	BofA Securities	Buy	$30

Show Previous Ratings

May-28-25 04:00PM	Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire)
May-13-25 12:00PM	Caribou Biosciences (CRBU) Upgraded to Buy: Here's What You Should Know (Zacks)
May-08-25 05:25PM	Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
May-06-25 04:00PM	Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference (GlobeNewswire) -12.16%
10:01AM	Loading…
May-01-25 10:01AM	Will Clearside Biomedical, Inc. (CLSD) Report Negative Q1 Earnings? What You Should Know (Zacks) -5.77%
Apr-29-25 10:01AM	Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should Know (Zacks) +10.44%
Apr-25-25 07:50AM	Caribou cuts pipeline and workforce to focus on lead CAR-T programmes (Pharmaceutical Technology) -11.30%
05:00AM	Caribou, in reversal, scraps autoimmune cell therapy and cuts staff (BioPharma Dive)
Apr-24-25 04:15PM	Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs (GlobeNewswire)
08:10AM	Bristol Myers Squibb (BMY) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
Mar-10-25 05:15PM	Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update (GlobeNewswire)
Feb-18-25 04:05PM	Caribou Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire) +5.19%
05:45AM	Shareholders of Caribou Biosciences, Inc. Should Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your Rights - CRBU (PR Newswire)
05:45AM	Loading…
Feb-07-25 05:45AM	Caribou Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your Rights - CRBU (PR Newswire)
Jan-31-25 05:45AM	Caribou Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CRBU (PR Newswire) +9.16%
Jan-24-25 05:45AM	Caribou Biosciences, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your Rights - CRBU (PR Newswire)
Jan-17-25 05:45AM	Caribou Biosciences, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your Rights - CRBU (PR Newswire)
Jan-14-25 05:45AM	Investors in Caribou Biosciences, Inc. Should Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your Rights - CRBU (PR Newswire)
Jan-12-25 07:05PM	Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025 (GlobeNewswire)
Jan-07-25 04:00PM	Caribou Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -8.02%
Jan-02-25 08:00AM	Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer (GlobeNewswire) +5.66%
Dec-30-24 03:01PM	Why Is Caribou Biosciences Inc. (CRBU) Among the Top CRISPR Stocks to Invest In? (Insider Monkey)
Dec-16-24 09:55AM	Caribou Biosciences (CRBU) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks)
Nov-20-24 04:00PM	Caribou Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-06-24 06:05PM	Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Lags Revenue Estimates (Zacks) +7.42%
04:05PM	Caribou Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Oct-31-24 03:53AM	Is Caribou Biosciences (CRBU) a Promising Gene Editing Stock? (Insider Monkey)
Oct-17-24 03:06PM	STATE STREET CORP's Strategic Acquisition in Caribou Biosciences Inc (GuruFocus.com) -5.83%
09:00AM	Loading…
Sep-25-24 09:00AM	Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024 (GlobeNewswire)
Sep-03-24 08:00AM	Caribou Biosciences Announces the FDA has Granted Fast Track Designations to CB-010 in Refractory SLE and to CB-012 in Relapsed or Refractory AML (GlobeNewswire) -8.33%
Aug-26-24 04:00PM	Caribou Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-12-24 08:00AM	Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer (GlobeNewswire)
Aug-06-24 06:50PM	Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
10:00AM	Caribou Biosciences, Inc. (CRBU) May Report Negative Earnings: Know the Trend Ahead of Q2 Release (Zacks)
Jul-17-24 07:45AM	Caribou lays off staff; Roche walks away from Relay (BioPharma Dive)
Jul-09-24 08:00AM	Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board (GlobeNewswire)
Jun-02-24 07:00PM	Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
May-30-24 04:01PM	Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences (GlobeNewswire)
May-12-24 04:00PM	3 Underappreciated Stocks That Could 10x in 10 Years (InvestorPlace)
May-09-24 05:23AM	Truist Adjusts Price Target on Caribou Biosciences to $19 From $21, Maintains Buy Rating (MT Newswires)
May-07-24 10:55PM	CRBU Stock Earnings: Caribou Biosciences Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) -6.17%
05:25PM	Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-01-24 04:05PM	Caribou Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
Apr-27-24 06:00AM	Bragar Eagel & Squire is Investigating Certain Officers and Directors of Caribou, Verrica, and Playstudios on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm (GlobeNewswire)
Apr-24-24 10:00AM	Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
Apr-15-24 09:00AM	Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) (GlobeNewswire)
Apr-04-24 04:00PM	Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus (GlobeNewswire)
Mar-14-24 12:00PM	All You Need to Know About Caribou Biosciences, Inc. (CRBU) Rating Upgrade to Buy (Zacks)
Mar-13-24 03:32PM	11 Oversold NASDAQ Stocks To Buy Right Now (Insider Monkey) +11.55%
Mar-12-24 12:37PM	Why Caribou Biosciences Stock Is Crashing Today (Motley Fool) -30.47%
Mar-11-24 04:05PM	Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-05-24 04:30PM	Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting (GlobeNewswire)
Feb-26-24 01:14PM	12 $10 Stocks That Will Triple (Insider Monkey) +6.92%
06:45AM	Missed Out on CRISPR Therapeutics? My Best Gene-Editing Stock to Buy and Hold (Motley Fool)
Feb-23-24 11:25PM	Steven Cohen's Point72 Adds Caribou Biosciences Inc to Its Portfolio (GuruFocus.com)
Feb-15-24 04:05PM	Caribou Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-12-24 08:30AM	2 Risky Gene-Editing Stocks to Buy in the New Bull Market if You Dare (Motley Fool)
Jan-15-24 08:45AM	3 Biotech Stocks You Can Buy and Hold for the Next Decade (Motley Fool)
Jan-07-24 11:00AM	Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024 (GlobeNewswire)
Dec-13-23 07:26AM	5 Things to Know Before The Stock Market Opens (Investopedia)
05:20AM	3 Gene-Editing Stocks With the Potential to Mint Millionaires (InvestorPlace)
Dec-12-23 04:02PM	Caribou Biosciences Provides Regulatory Update on CB-010 Pivotal Plan with Phase 3 Trial Initiation Expected by YE 2024 (GlobeNewswire)
Dec-08-23 12:00PM	Caribou Biosciences, Inc. (CRBU) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Dec-06-23 09:55AM	Wall Street Analysts Believe Caribou Biosciences, Inc. (CRBU) Could Rally 285.29%: Here's is How to Trade (Zacks)
Nov-20-23 09:55AM	Does Caribou Biosciences, Inc. (CRBU) Have the Potential to Rally 321.46% as Wall Street Analysts Expect? (Zacks) +6.51%
Nov-07-23 04:00PM	Caribou Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) -5.03%
Nov-06-23 08:00AM	Caribou Biosciences Announces Appointment of Sundar Jagannath, MD, to its Scientific Advisory Board (GlobeNewswire) +14.11%
Nov-01-23 04:05PM	Caribou Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-20-23 05:00AM	2 Top Growth Stocks to Buy Right Now Without Hesitation (Motley Fool)
Oct-18-23 08:00AM	Caribou Biosciences Announces FDA Clearance of IND Application for CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (GlobeNewswire) -6.00%
Oct-11-23 06:00AM	2 Exciting Biotech Stocks to Buy With Less Than $10 (Motley Fool)
Oct-10-23 05:40AM	A Bull Market Is Coming: 1 Beaten-Down Growth Stock You Could Regret Not Buying on the Dip (Motley Fool)
Oct-05-23 10:07AM	Avoid Big Losses With Biotech Stocks by Paying Attention to These 2 Things (Motley Fool)
Sep-27-23 08:30AM	2 Magnificent Growth Stocks to Buy On the Dip (Motley Fool)
08:00AM	Caribou Biosciences Appoints Reigin Zawadzki as Chief People Officer (GlobeNewswire)
Sep-23-23 08:45AM	1 Gene Editing Stock to Buy Now, and 1 to Sell (Motley Fool)
Aug-29-23 04:00PM	Caribou Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-24-23 05:58AM	3 Clever Tricks to Find Winning Biotech Stocks (Motley Fool)
Aug-15-23 04:08PM	Robert Bruce's Q2 2023 13F Filing Update: Key Trades and Portfolio Overview (GuruFocus.com)
03:08PM	Is Caribou Biosciences (CRBU) Stock Outpacing Its Medical Peers This Year? (Zacks)
Aug-08-23 05:15PM	Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +5.81%
04:00PM	Caribou Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Jul-28-23 08:30AM	3 Reasons Why Caribou Biosciences Is a Screaming Buy in July and Beyond (Motley Fool) +7.05%
Jul-22-23 09:45AM	This 1 Innovation Could Make These 2 Biotechs Soar by 2030 (Motley Fool)
Jul-21-23 10:00AM	Got $1,000? Buying Caribou Biosciences Stock Right Now Could Be a Brilliant Move in 5 Years (Motley Fool)
Jul-20-23 11:35AM	2 Growth Stocks That Could Rocket 81% to 233% Higher, According to Wall Street (Motley Fool)
Jul-19-23 09:30AM	Caribou Biosciences, Inc. (CRBU) Just Overtook the 200-Day Moving Average (Zacks)
Jul-17-23 05:03PM	2 Stocks I'm Buying on the Dip This Week (Motley Fool) +9.86%
Jul-14-23 11:27AM	Caribou Biosciences Raises $125M Via Equity Just One Week After Pfizer Invested $25M (Benzinga) -22.60%
Jul-13-23 11:15PM	Caribou Biosciences Announces Pricing of Upsized $125 Million Public Offering (GlobeNewswire)
04:03PM	Caribou Biosciences Announces Proposed Public Offering of Common Stock (GlobeNewswire)
04:01PM	CORRECTED-Caribou's cell therapy shows promise in early-stage cancer study (July 13) (Reuters)
04:01PM	Caribou Biosciences Reports Positive Clinical Data from Dose Escalation of CB-010 ANTLER Phase 1 Trial in r/r B-NHL (GlobeNewswire)
09:30AM	2 Magnificient Growth Stocks to Buy in July (Motley Fool)
Jul-12-23 09:40AM	Is Caribou Biosciences (CRBU) Outperforming Other Medical Stocks This Year? (Zacks)
Jul-11-23 09:55AM	How Much Upside is Left in Caribou Biosciences, Inc. (CRBU)? Wall Street Analysts Think 316.72% (Zacks) +15.81%

Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Haurwitz Rachel E.	President and CEO	Mar 14 '25	Buy	1.02	20,000	20,400	3,369,395	Mar 17 08:01 AM
MCCLUNG BARBARA G	Chief Legal Officer	Feb 21 '25	Sale	1.35	3,564	4,811	443,502	Feb 21 08:19 PM
Khan Ruhi Ahmad	Chief Business Officer	Feb 21 '25	Sale	1.35	3,564	4,811	66,936	Feb 21 08:19 PM
Kanner Steven	Chief Scientific Officer	Feb 21 '25	Sale	1.35	3,564	4,811	431,556	Feb 21 08:18 PM
Ryali Sriram	Chief Financial Officer	Jan 29 '25	Buy	1.42	17,360	24,651	17,360	Jan 30 04:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CRBU

Caribou Biosciences Inc

Upgrade your FINVIZ experience